pp65 antigenemia and real time polymerase chain reaction (PCR) based-study to determine the prevalence of human cytomegalovirus (HCMV) in kidney donors and recipients with follow-up studies

Virology Journal

Volumn 7, Issue , 2010, Pages

  Madhavan, Hajib N ^a   Samson, Moses Y ^a   Ishwarya, Murali ^a   Vijayakumar, Ramanathan ^b   Jambulingam, Malathi ^a  

^a Sankara Nethralaya   (India)

^b Billroth Hospitals   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOMEGALOVIRUS ANTIGEN PP65; UNCLASSIFIED DRUG; VALCEPT; VALGAN; VALGANCICLOVIR; VIRUS DNA; CYTOMEGALOVIRUS MATRIX PROTEIN 65KDA; MATRIX PROTEIN; PHOSPHOPROTEIN;

ADULT; ARTICLE; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HUMAN CYTOMEGALOVIRUS; KIDNEY DONOR; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYMPTOM; VIRUS DETECTION; BLOOD; CYTOMEGALOVIRUS; DONOR; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MIDDLE AGED; POLYMERASE CHAIN REACTION; TRANSPLANTATION;

HUMAN HERPESVIRUS 5;

ADULT; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PHOSPHOPROTEINS; POLYMERASE CHAIN REACTION; PREVALENCE; TISSUE DONORS; TRANSPLANTATION; VIRAL MATRIX PROTEINS;

EID: 78149493616     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-7-322     Document Type: Article

References (17)

1. Monitoring human cytomegalovirus infection in transplant recipients. F Baldanti D Lilleri G Gerna, J Clin Virology 2008 41 237 241 10.1016/j.jcv.2007. 12.001
2. Role of quantitative human cytomegalovirus PCR in predicting antiviral treatment response among high-risk hematopoietic stem-cell transplant recipients. A Safdar M Bruorton JP Henslee-Downey F van Rhee, Bone Marrow Transplant 2004 33 463 464 10.1038/sj.bmt.1704375 14716349
3. Donor and recipient CMV serostatus and antigenemia after renal transplantation: An analysis of 486 patients. D Hughes J Hafferty L Fulton P Friend A Devaney J Loke KI Welsh A Handa P Klenerman, J Clin Virol 2008 41 92 95 10.1016/j.jcv.2007.10.006 18032098
4. Donated organs as a source of cytomegalovirus (CMV) in renal transplant patients. SC Costa SR Miranda G Alves CL Rossi LT Fiqueiredo FF Costa, Braz J Med Biol Res 1994 27 2573 8 7549979
5. Immunotherapy for malignancies and viral infections. Current Opinion in Organ. M Cliona E Helen, Curr Opin Organ Transplant 2000 5 197 202 10.1097/00075200-200009000-00005
6. CMV mismatch does not affect patient and graft survival in UK renal transplant recipients. RJ Johnson MR Clatworthy R Birch A Hammad JA Bradley, Transplantation 2009 88 77 82 10.1097/TP.0b013e3181aa8d36 19584684
7. Cytomegalovirus-specific CD8+ T cells do not develop in all renal transplant patients at risk of virus infection. SE Christmas D Halliday N Lawton H Wang I Abdalla J Masters RL Hassan IJ Hart N Khan J Smith A Hammad A Bakran, Transplan Immunol 2009 22 99 104 10.1016/j.trim.2009.07.003
8. Effect of Cytomegalovirus Viremia on Subclinical Rejection or Interstitial Fibrosis and Tubular Atrophy in Protocol Biopsy at 3 Months in Renal Allograft Recipients Managed by Preemptive Therapy or Antiviral Prophylaxis. T Reischig J Pavel H Ondrej B Mirko K Stanislav T Vladislav, Transplantation 2009 87 436 444 10.1097/TP.0b013e318192ded5 19202451
9. Antibody response to cytomegalovirus after renal transplantation: Comparison of patients with primary and recurrent infections. RF Pass PD Griffiths AM August, J Infect Dis 1983 147 40 46 6296241
10. Surveillance of cytomegalovirus after solid- organ transplantation: comparison of pp65 antigenemia assay with a quantitative DNA hybridization assay. W Bossart K Bienz W Wunderli, J Clin Microbiol 1997 35 3303 3304 9399540
11. Relationship between pp65 antigenemia levels and real-time quantitative DNA PCR for Human Cytomegalovirus (HCMV) management in immunocompromised patients. EP Cariani CP Pollara B Valloncini F Perandin C Bonfanti N Manca, BMC Infect Dis 2007 7 1471 2334 10.1186/1471-2334-7-138 (Pubitemid 351211017)
12. Therapeutic implication of quantitative pp65 antigen assay in living renal transplant in a high seroendemic population. RW Minz M Minz M Kashyap M Heer N Udgiri K Joshi VK Sakhuja, Transplant Proc 2004 36 2120 2121 10.1016/j.transproceed.2004.08.106 15518768
13. Clinical usefulness of human cytomegalovirus antigenemia assay after kidney transplantation. Kim C Kwan, Transplantation 2003 75 2151 2155 10.1097/01.TP.0000066807.91219.F7 12829929
14. Infections after kidney transplantation. CME Coverage, based on Renal Week 2002: American Society of Nephrology 35th Annual Meeting. Medscape. OE Emovon GM Baillie PR Rajagopalan KD Chavin, Transplantation 2002 http://www.medscape.com/viewarticle/445262
15. Cytomegalovirus infection in a seroendemic renal transplant population: a longitudinal study of virological markers. M Rao GJ Finny P Abraham R Juneja PP Thomas CK Jacob G Sridharan, Nephron 2000 84 367 73 10.1159/000045613 10754415
16. Seroprevalence of Cytomegalovirus among Voluntary Blood Donors in Delhi, India. A Kothari VG Ramachandran P Gupta B Singh V Talwar, J Health Popul Nutr 2002 20 348 351 12659416
17. Development and application of a novel multiplex polymerase chain reaction for semi-quantitation of Human Cytomegalovirus in clinical specimens. HN Madhavan P Sowmya KL Therese J Malathi, J Virol Methods 2007 141 166 172 10.1016/j.jviromet.2006.12.003 17222918